The nation of Zimbabwe has turned down a significant American healthcare agreement worth 367 million US dollars (272 million pounds) spanning five years because of the United States' request for confidential data.
This rejection came to light after a government memo from December was disclosed, revealing that Head of State Emmerson Mnangagwa felt the arrangement was "unbalanced".
An official spokesman later clarified that the US was demanding access to genetic material for scientific study and profit while refused to share the benefits from future vaccines.
"We must now begin the challenging and unfortunate task of scaling back our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy said the US had provided over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has urged further negotiations to reach a deal acceptable to all parties so the nation's vital HIV treatment initiative can proceed.
Wider Background
This rejection comes after a comparable case in neighbouring Kenya, where a high court blocked a similar health funding agreement after legal challenges were filed about the safety of citizens' health data.
Since resuming office recently, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
USAID had overseen assistance for the US government, but Trump argued its expenditure was "wasteful" and his government was seeking direct bilateral agreements to boost transparency and accountability.
As per reports, Sixteen African countries have to date agreed to similar health pacts, representing more than $18.3bn in committed funds.
Details of the Rejected Deal
The funds for Zimbabwe would have supported "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this partnership could have provided significant advantages for Zimbabwean communities, particularly the 1.2 million men, women and children presently on HIV treatment via US-supported initiatives," the Ambassador added.
However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".
"Zimbabwe was being asked to surrender its genetic material and health information over an extended period, with no equivalent assurance of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might result from that provided information," his statement read.
"Effectively, our country would supply the basic resources for medical research without any assurance that the final treatments would be available to our population if a future disease outbreak arise."
National Interest and International Frameworks
Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one deals were upending structures already set up through the global organization.
Mangwana cited its Pathogen Access and Benefit Sharing framework designed to manage future global health emergencies.
"This system is intended to guarantee that when a nation contributes its samples, the benefits – including medicines and cures – are shared equitably, not commercialised solely by those with the funds to develop them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as anti-American sentiment," he added.
"We welcome further discussions with our American counterparts on how subsequent co-operation could be designed in a manner that honours the sovereignty and dignity of each country."
Medical Community Response
Medical experts stated it acknowledged the official position, but recommended that negotiations must proceed given that much of the nation's HIV programmes relied on foreign aid.
"Where specific concerns arise, such as those involving information security or agreement terms, these can frequently be addressed via technical clarification and mutually agreed protections," it added.
The situation underscores the ongoing challenges between accepting crucial international aid and protecting national sovereignty in an ever more interconnected world.